Sampling time [Design Issues]

posted by Durga – India, 2018-08-14 09:37 (2378 d 08:06 ago) – Posting: # 19167
Views: 3,894

We need to check the molecule available PK profile of drug (absorption, distribution and elimination). we need to read the guidelines how many sampling time points need to be set at different phases as per above mentioned.

you need to check the metabolite pharmacological activity (if applicable)

bases on the formulation also. it is also very important.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
55 visitors (0 registered, 55 guests [including 7 identified bots]).
Forum time: 16:44 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5